F. Yin

发表

ACTR-66. A PHASE 1, OPEN-LABEL, PERIOPERATIVE STUDY OF IVOSIDENIB (AG-120) AND VORASIDENIB (AG-881) IN RECURRENT IDH1 MUTANT, LOW-GRADE GLIOMA: UPDATED RESULTS

Jennie W. Taylor, E. Maher, P. Wen, 2019, Neuro-Oncology.

Pharmacokinetic/Pharmacodynamic Evaluation of Ivosidenib or Enasidenib Combined With Intensive Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed IDH1/2‐Mutant Acute Myeloid Leukemia

Hua Yang, L. Hua, Yue Chen, 2022, Clinical pharmacology in drug development.

A phase I, open label, perioperative study of AG-120 and AG-881 in recurrent IDH1 mutant, low-grade glioma: Results from cohort 1.

Jennie W. Taylor, E. Maher, P. Wen, 2019, Journal of Clinical Oncology.